| Cover | Aug. 30, 2022 |
| Cover [Abstract] | |
| Entity Registrant Name | NASCENT BIOTECH INC. |
| Entity Central Index Key | 0001622057 |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Entity Emerging Growth Company | false |
| Document Period End Date | Aug. 30, 2022 |
| Entity Incorporation State Country Code | NV |
| Entity Tax Identification Number | 45-0612715 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Entity File Number | 000-55299 |
| Entity Address Address Line 1 | 623 17th Street Suite 4 |
| Entity Address City Or Town | Vero Beach |
| Entity Address State Or Province | FL |
| Entity Address Postal Zip Code | 32960 |
| City Area Code | 612 |
| Local Phone Number | 961-5656 |
| Amendment Description | On September 2, 2022, Nascent Biotech Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) with the Securities and Exchange Commission to report, among other things, the percentage of share ownership that YA II PN, Ltd. would own upon conversion of the Debenture would not exceed 4.99% (all as defined in the Original Report). This Amendment No. 1 is being furnished for the purpose of correcting Item 1.01 of the Original Report to disclose that the percentage of ownership by YA II PN, Ltd. will not exceed 9.99% upon conversion of the Debenture. |
